Letter: Treatment of post-anoxic intention myoclonus.
D006916:5-Hydroxytryptophan / Q000008:administration & dosage / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D002230:Carbidopa / Q000627:therapeutic use; D004341:Drug Evaluation; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000008:administration & dosage / Q000627:therapeutic use*; D000860:Hypoxia / Q000150:complications; D008297:Male; D008784:Methysergide / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D009207:Myoclonus / Q000188:drug therapy* / Q000209:etiology
D006834:Hydrazines; D006916:5-Hydroxytryptophan; D002230:Carbidopa; D008784:Methysergide